Showing 41–50 of 75 results from Publika

Martin FL, Chen HH, Cataliotti A, Burnett JC (2008)
B-type natriuretic peptide: beyond a diagnostic
Heart Fail Clin, 4 (4), 449-54
PubMed 18760756 DOI 10.1016/j.hfc.2008.03.011
Hawkridge AM, Muddiman DC, Hebulein DM, Cataliotti A, Burnett JC (2008)
Effect of plasma protein depletion on BNP-32 recovery
Clin Chem, 54 (5), 933-4
PubMed 18443186 DOI 10.1373/clinchem.2007.098038
Martin FL, Chen HH, Cataliotti A, Burnett JC (2008)
Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators
Rev Cardiovasc Med, 9 (1), 39-45
PubMed 18418308
Costello-Boerrigter LC, Boerrigter G, Harty GJ, Cataliotti A, Redfield MM, Burnett JC (2007)
Mineralocorticoid escape by the kidney but not the heart in experimental asymptomatic left ventricular dysfunction
Hypertension, 50 (3), 481-8
PubMed 17635858 DOI 10.1161/HYPERTENSIONAHA.107.088534
Heublein DM, Huntley BK, Boerrigter G, Cataliotti A, Sandberg SM, Redfield MM, Burnett JC (2007)
Immunoreactivity and guanosine 3',5'-cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptide
Hypertension, 49 (5), 1114-9
PubMed 17372040 DOI 10.1161/HYPERTENSIONAHA.106.081083
Boerrigter G, Costello-Boerrigter LC, Cataliotti A, Lapp H, Stasch JP, Burnett JC (2007)
Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure
Hypertension, 49 (5), 1128-33
PubMed 17325237 DOI 10.1161/HYPERTENSIONAHA.106.083832
Huntley BK, Sandberg SM, Noser JA, Cataliotti A, Redfield MM, Matsuda Y, Burnett JC (2006)
BNP-induced activation of cGMP in human cardiac fibroblasts: interactions with fibronectin and natriuretic peptide receptors
J Cell Physiol, 209 (3), 943-9
PubMed 16986166 DOI 10.1002/jcp.20793
Chen HH, Huntley BK, Schirger JA, Cataliotti A, Burnett JC (2006)
Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure
J Am Soc Nephrol, 17 (10), 2742-7
PubMed 16928803 DOI 10.1681/ASN.2006020161
Belluardo P, Cataliotti A, Bonaiuto L, Giuffrè E, Maugeri E, Noto P, Orlando G, Raspa G, Piazza B, Babuin L, Chen HH, Martin FL, McKie PM, Heublein DM, Burnett JC, Malatino LS (2006)
Lack of activation of molecular forms of the BNP system in human grade 1 hypertension and relationship to cardiac hypertrophy
Am J Physiol Heart Circ Physiol, 291 (4), H1529-35
PubMed 16648193 DOI 10.1152/ajpheart.00107.2006
McKie PM, Rodeheffer RJ, Cataliotti A, Martin FL, Urban LH, Mahoney DW, Jacobsen SJ, Redfield MM, Burnett JC (2006)
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure
Hypertension, 47 (5), 874-80
PubMed 16585413 DOI 10.1161/01.HYP.0000216794.24161.8c